Published in Clin Appl Thromb Hemost on October 12, 2011
Prediction of chemotherapeutic response in bladder cancer using K-means clustering of dynamic contrast-enhanced (DCE)-MRI pharmacokinetic parameters. J Magn Reson Imaging (2014) 0.89
Improving bladder cancer imaging using 3-T functional dynamic contrast-enhanced magnetic resonance imaging. Invest Radiol (2014) 0.83
Pulmonary MRA: differentiation of pulmonary embolism from truncation artefact. Eur Radiol (2014) 0.77
The presurgical T staging of non-small cell lung cancer: efficacy comparison of 64-MDCT and 3.0 T MRI. Cancer Imaging (2015) 0.75
Magnetic resonance angiography using fresh blood imaging in oral and maxillofacial regions. Int J Dent (2012) 0.75
Contrast-enhanced pulmonary MRA for the primary diagnosis of pulmonary embolism: current state of the art and future directions. Br J Radiol (2017) 0.75
Multidetector computed tomography for acute pulmonary embolism. N Engl J Med (2006) 7.57
Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). JAMA (1990) 5.37
Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III). Ann Intern Med (2010) 4.15
ACR guidance document for safe MR practices: 2007. AJR Am J Roentgenol (2007) 4.12
Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology (2007) 2.79
Chronic thromboembolism: diagnosis with helical CT and MR imaging with angiographic and surgical correlation. Radiology (1997) 1.51
Intraindividual comparison of high-spatial-resolution abdominal MR angiography at 1.5 T and 3.0 T: initial experience. Radiology (2007) 1.01
Methods of Prospective Investigation of Pulmonary Embolism Diagnosis III (PIOPED III). Semin Nucl Med (2008) 1.00
Effect of field strength on susceptibility artifacts in magnetic resonance imaging. Comput Med Imaging Graph (1991) 0.99
Contrast-enhanced MRA in pre-embolization assessment of a pulmonary arteriovenous malformation. J Magn Reson Imaging (1997) 0.88
Optimization of contrast dosage for gadolinium-enhanced 3D MRA of the pulmonary and renal arteries. Magn Reson Imaging (1998) 0.88
Suspected pulmonary embolism: prospective evaluation with pulmonary MR angiography. Radiology (1993) 0.87
Contrast-enhanced MRA and 3D visualization of pulmonary venous anatomy to assist radiofrequency catheter ablation. J Cardiovasc Magn Reson (2003) 0.87
3.0 Tesla high spatial resolution contrast-enhanced magnetic resonance angiography (CE-MRA) of the pulmonary circulation: initial experience with a 32-channel phased array coil using a high relaxivity contrast agent. Invest Radiol (2007) 0.87
Pulmonary angiography with MR imaging: preliminary clinical experience. Radiology (1993) 0.87
Pulmonary embolism: comparison of MR images with radionuclide and angiographic studies. Radiology (1994) 0.87
Dynamic pulmonary perfusion and flow quantification with MR imaging, 3.0T vs. 1.5T: initial results. J Magn Reson Imaging (2006) 0.83
Pulmonary vascular cine MR imaging: a noninvasive approach to dynamic imaging of the pulmonary circulation. Radiology (1990) 0.83
Clinical evaluation of pulmonary 3D time-of-flight MRA with breath holding using contrast media. J Comput Assist Tomogr (1996) 0.82
High-resolution pulmonary arterio- and venography using multiple-bolus multiphase 3D-Gd-mRA. J Magn Reson Imaging (1999) 0.82
[Comparative study of pulmonary magnetic resonance angiography (MRA)]. Hunan Yi Ke Da Xue Xue Bao (2000) 0.79
Quantitative 3D VUSE pulmonary MRA. Magn Reson Imaging (1999) 0.78
Contrast-enhanced MR angiography. Abdom Imaging (1998) 0.78
Accuracy of contrast-enhanced magnetic resonance angiography in chronic thromboembolic disease. Acad Radiol (1996) 0.78
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med (2002) 101.79
10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet (2009) 15.00
Multimodal fast optical interrogation of neural circuitry. Nature (2007) 14.68
Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology (2005) 9.83
Angiotensin-converting-enzyme inhibition in stable coronary artery disease. N Engl J Med (2004) 9.67
Light activation of channelrhodopsin-2 in excitable cells of Caenorhabditis elegans triggers rapid behavioral responses. Curr Biol (2005) 8.01
TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N Engl J Med (2006) 7.75
Multidetector computed tomography for acute pulmonary embolism. N Engl J Med (2006) 7.57
Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia (2009) 7.44
D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review. Ann Intern Med (2004) 6.15
A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med (2009) 5.81
Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 4.83
Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin. Diabetes (2005) 4.81
Coronary CT angiography versus standard evaluation in acute chest pain. N Engl J Med (2012) 4.72
Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci U S A (2005) 4.63
Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest (2007) 4.49
Gadolinium-enhanced magnetic resonance angiography for pulmonary embolism: a multicenter prospective study (PIOPED III). Ann Intern Med (2010) 4.15
Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children. PLoS Med (2011) 3.94
The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Ann Intern Med (2010) 3.56
Clinical characteristics of patients with acute pulmonary embolism: data from PIOPED II. Am J Med (2007) 3.16
Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. Proc Natl Acad Sci U S A (2005) 3.15
Cardiac memory in patients with Wolff-Parkinson-White syndrome: noninvasive imaging of activation and repolarization before and after catheter ablation. Circulation (2008) 3.09
Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma. J Clin Oncol (2010) 2.90
Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival. J Clin Oncol (2008) 2.84
Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program. Diabetes (2005) 2.80
Genetically encoded calcium indicators for multi-color neural activity imaging and combination with optogenetics. Front Mol Neurosci (2013) 2.79
Hepatic fat fraction: MR imaging for quantitative measurement and display--early experience. Radiology (2005) 2.69
Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiple-cause mortality data. Arch Intern Med (2003) 2.64
Interleukin-6 overexpression induces pulmonary hypertension. Circ Res (2008) 2.64
64-slice CT for diagnosis of coronary artery disease: a systematic review. Am J Med (2008) 2.57
Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program. Am J Clin Nutr (2008) 2.55
Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: effect on arterial phase image quality. Radiology (2012) 2.53
Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: the strong heart study. Diabetes Care (2003) 2.40
Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial. J Am Coll Cardiol (2007) 2.40
Optogenetic analysis of synaptic function. Nat Methods (2008) 2.38
The parametric response map is an imaging biomarker for early cancer treatment outcome. Nat Med (2009) 2.32
Management of suspected acute pulmonary embolism in the era of CT angiography: a statement from the Fleischner Society. Radiology (2007) 2.30
The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome. Neoplasia (2006) 2.30
Evaluation of cancer therapy using diffusion magnetic resonance imaging. Mol Cancer Ther (2003) 2.28
Acute pulmonary embolism: sensitivity and specificity of ventilation-perfusion scintigraphy in PIOPED II study. Radiology (2008) 2.25
ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. J Am Coll Cardiol (2010) 2.23
Real-time multimodal optical control of neurons and muscles in freely behaving Caenorhabditis elegans. Nat Methods (2011) 2.19
Updated genetic score based on 34 confirmed type 2 diabetes Loci is associated with diabetes incidence and regression to normoglycemia in the diabetes prevention program. Diabetes (2011) 2.17
3D MRI-based multicomponent FSI models for atherosclerotic plaques. Ann Biomed Eng (2004) 2.17
ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. Circulation (2010) 2.14
Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II investigators. Am J Med (2006) 2.13
Very low probability interpretation of V/Q lung scans in combination with low probability objective clinical assessment reliably excludes pulmonary embolism: data from PIOPED II. J Nucl Med (2007) 2.12
Fibrosing interstitial lung disease. A practical high-resolution computed tomography-based approach to diagnosis and management and a review of the literature. Am J Respir Crit Care Med (2013) 2.10
A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy. Transl Oncol (2009) 2.10
Diagnostic pathways in acute pulmonary embolism: recommendations of the PIOPED II Investigators. Radiology (2007) 2.09
Are vena cava filters effective in the treatment of pulmonary embolism? Am J Med (2013) 2.02
Light-controlled tools. Angew Chem Int Ed Engl (2012) 1.96
Noninvasive real-time imaging of apoptosis. Proc Natl Acad Sci U S A (2002) 1.93
Local maximal stress hypothesis and computational plaque vulnerability index for atherosclerotic plaque assessment. Ann Biomed Eng (2005) 1.89
Focal atrial tachycardia after pulmonary vein isolation: noninvasive mapping with electrocardiographic imaging (ECGI). Heart Rhythm (2007) 1.88
Early microbiological response to linezolid vs vancomycin in ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus. Chest (2008) 1.87
Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. Chest (2006) 1.84